Impact of Stress Management Training After Cardiac Transplantation

NCT ID: NCT02163629

Last Updated: 2015-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In spite of major medical advances in heart transplant patients, psychiatric comorbidity remains very high in pre-and post-transplant phases. Anxiety and depression are especially frequent. They impact significantly morbidity and mortality. Especially because they are associated with poor therapeutic adherence and risks of infection and rejection. The inability to make beneficial therapeutic choice can be explained by the negative perception of events, associated with anxio-depressive disorders. This results in an important deterioration in quality of life of patients.

The investigators assume that better management of emotions might reduce the stress of waiting situation and its psychopathological and somatic consequences pre-and post-transplant.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Transplant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

psychotherapeutic intervention

The psychotherapeutic intervention "stress management" is based on therapeutic, behavioral and cognitive strategies. They are active and put the patient "actor" of his "adaptation" of the heart transplantation entire process. The approached components are emotional, cognitive and behavioral (techniques of communication and problem solving).

Group Type EXPERIMENTAL

Stress management

Intervention Type BEHAVIORAL

Usual medical care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress management

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

The program of "stress management" will include six group sessions at a rate of one session of 2 hours every 15 days. 6 components will be approached: - stress and relaxation - cognitive strategies of the stress adaptation - communication techniques and stress - problem solving techniques and stress - stress adaptation - generalization of stress management in everyday situations

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women on the cardiac transplantation waiting list
* Patients aged 18 years and older
* Signed written informed consent
* Patients under the social security
* Patients with a somatic condition allowing travels
* Patients mastering the French language
* Class II or III NYHA patients

Exclusion Criteria

* Patients minor or under protection measures
* Patient who have not signed written informed consent
* Patients not mastering the French language
* Patients with psychiatric illness characterized by the axis 1 of DSM IV R
* Patients receiving a psychotherapy or with a psychiatric care
* class IV NYHA patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed SAOUD, Pr

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Psychiatrie d'Adultes Liaison/Consultation,

Bron, , France

Site Status RECRUITING

Pôle de Psychiatrie et de Neurologie

Grenoble, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohamed SAOUD, Pr

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamed SAOUD, PR

Role: primary

4 72 11 80 64 ext. +33

Thierry BOUGEROL, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-842

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

iCBT for Cardiac Anxiety in Patients With NCCP
NCT06136494 ACTIVE_NOT_RECRUITING NA
Improving Sleep for Healthy Hearts
NCT02848859 COMPLETED NA